Loading summary
Dr. Sanjay Gupta
Welcome to chasing life. If you've ever gone to the doctor to talk about pain, then you've probably had to go through some typical dance of giving that pain a score from 1 to 10. Maybe you were shown a scale of smiley faces to sad faces and maybe you also thought at that time, this is a little crazy. This is the best we can do to measure pain with basically emojis. When a man named Ed Mowry stepped into Dr. Prasad Srivalkar's office in 2021, he had undoubtedly answered that question hundreds of times. I'm not exaggerating. He was 51 years old and had been suffering from complex regional pain syndrome, chronic pain, since he was 15. He described it as a sharp, stabbing burning over his entire body and he had no clear explanation why.
Dr. Prasad Srivalkar
When I first met Ed, he was in dire straits. He had had 25 surgeries, he was unable to work. He essentially was living in New Mexico with a dream, a dream that he's held for 20 years of producing an album. You know, he's a prolific musician, but it was the pain and everything that came along with the pain that really stood in the way of him meeting his dream.
Dr. Sanjay Gupta
So ed came to Dr. Shivalkar because he's a specialist in pain medicine at the University of California, San Francisco, but also because he is one of the world's leading researchers in developing something that is really revolutionary. He's basically using deep brain stimulation therapies for really hard to treat pain disorders. It's a lot, it's brain surgery. But the idea is that if we can locate where an individual's brain is interpreting or generating the pain, then perhaps that pain could be evaluated and even treated using personalized therapies and electrodes to stimulate that exact area. It's not easy. Pinpointing that particular spot in the brain is truly like finding a needle in a haystack.
Dr. Prasad Srivalkar
The whole team were in there for eight to 10 hours every day for 10 days, and we didn't find anything. Day after day. And I think it was day five or six that we had a kind of eureka moment when all of a sudden Ed says, my pain, you know, just washed off of me. I didn't know what to say. I could not understand how this could happen in a flash.
Dr. Sanjay Gupta
What I can only imagine felt like the culmination of a decades long battle for Ed also turned out to be a real turning point for Dr. Srivalkar. His work, it seemed, was not a fool's errand. So I wanted to hear all about it. I invited Dr. Srivalkar on the show today to talk about his research. The questions being, are we really close to finding a biomarker for pain? In other words, an objective, observable measurement? Think of it like blood pressure or cholesterol so that we don't need to rely on smiley faces anymore. Is that where we're headed? And at the same time, could deep brain stimulation therapies work in tandem with existing pain modalities? It's a fascinating conversation. It's about the future. And it's about something that affects 50 million people, at least in the United states alone. I'm Dr. Sanjay Gupta, CNN's chief medical correspondent, and this is Chasing Life.
Sleep Number Ad
We all sleep, but no two sleepers are the same. That's why Sleep Number Smart beds are designed to adapt to you. With Sleep Number it's easy and your side of the bed can be totally different from your partner's. Why choose a Sleep Number Smart bed so you can sleep just the way you like. The only bed that lets you make each side firmer or softer whenever you like your Sleep Number setting. And now save up to $800 on select sleep Number Smart Beds limited time exclusively at a Sleep Number store near you. See store or sleepnumber.com for details.
Uber Eats Ad
It's summer time to enjoy long days, lazy nights and great food because Uber Eats has deals all summer long. So when hunger strikes, don't sweat it. Delicious deals are just a tap away on Uber Eats. Enjoy all your favorite grocery items delivered straight to you. Get ice cream soda and snacks from your favorite stores like Wegmans and cvs and make the most of every moment. Now that sounds like a good summer order. Now on UberEats Terms, apply. Product availability varies by region. See how for details.
Interviewer
The FDA typically approves 40 to 50 new drugs a year on average for all sorts of different things. But in the last quarter century, not a single new drug for pain until this spring. Is there just not interest in this? Is it purely the complexity of it, or what do you think is driving that?
Dr. Prasad Srivalkar
You know, I think one of the big challenges is how do we develop a pain therapy that's not addictive, that doesn't have side effects that are going to harm people? And for so long I think there's been a bit of a monopoly from the opiate manufacturers on marketing in pain as well as distributing materials to physicians where that was the kind of go to you go for the oxycodone or you go for the Norco. And I think people were making a lot of money with that approach. And so the money wasn't flowing elsewhere. And I think that was one policy obstacle.
Interviewer
Opioids sort of sucked all the oxygen up in the room.
Dr. Prasad Srivalkar
That's a good way to put it.
Interviewer
Let's just, you know, when people think about pain, there's all sorts of different potential tools. They think about over the counter medications, going to the doctor for injections. Can you just sort of, you take care of pain patients. How do you sort of approach somebody who comes to you with pain in terms of diagnosing it, measuring it, and then treating it? So let's start with diagnosis.
Dr. Prasad Srivalkar
Right, so diagnosis for pain is mostly clinical, which means we talk to the patient, try to understand the symptoms that they're experiencing, when they started, how they progressed, physical exam, you know, try to understand what is the pain generator. Are the nerves in your skin or peripheral nerves creating the pain? If the pain has been around long enough, it starts to change your spinal cord and change your brain. So we try to understand is this coming from the brain or the spinal cord. So when we diagnose certain pain disorders, it's really using guidelines and criteria to try to understand what box people might fit in or certain syndromes might fit in. Of course, we still call a lot of diagnoses syndromes, which means it's a collection of symptoms and signs that we don't fully understand. But, you know, we diagnose them based on what fits together. Of course, just because we observe that certain symptoms fit together doesn't mean we understand why they occur. So it doesn't immediately tell you how to treat it. And so it, it can be really challenging to diagnose pain. And often people will go for years without an accurate diagnosis. And for so long, chronic pain was thought just to be a symptom of some other disease. We're now recognizing that chronic pain is truly a disease in its own right.
Interviewer
So you got a sense of how to diagnose then someone's pain. You figure out what's generating the pain, you ask them about their symptoms. Objectifying the pain, now measuring it. How do you do that with a patient?
Dr. Prasad Srivalkar
Right. So for the longest time, pain was called the fifth vital sign. Right. But unlike the other four vital signs, there's no objective measure. It's not like temperature or heart rate. So one of the holy grails of pain medicine has been coming up with a biomarker for measuring how intense or how severe somebody's pain is. And so we know that there's a lot of activity in the brain that seems to correlate or seems to even predict in healthy folks how hot something might be, or in experimental tasks, for example, an FMRI. For the last 50 years, people have been trying to come up with a signature to predict how intense someone is experiencing pain. What we were able to do in my lab, using wires implanted in the brain, is actually identify not only experimental pain, but to try to understand how. Can we filter the brain signals to come up with an objective measure or a biomarker for how severe someone's chronic pain, real world pain, is, and can.
Interviewer
We do that now?
Dr. Prasad Srivalkar
We are beginning to scratch the surface on that now, and I'd say, you know, in five to 10 years, this kind of growth is usually exponential. I'm hoping to see some kind of personalized marker that might at least help us get a handle on what category someone's in, whether they're low pain or high pain. And especially useful in the hospital if someone can't communicate, you know, or if someone has dementia, for example, it's very hard often to know. And so a tool like this could be helpful, of course, for that population. But really, hopefully, it'll help us understand how each person experiences pain uniquely so that we could treat their pain better.
Interviewer
Are there pain centers in the brain that you can measure?
Dr. Prasad Srivalkar
Right. So of the amazing things in the brain, there's no single pain center in the brain, which is a real problem if you want to understand pain, and moreover, if you want to stimulate an area of the brain to treat pain. And so pain seems to be represented really like a network, like a mesh distributed across the brain. That's how we often see it with the MRI or functional MRI stuff. In reality, this network has a certain structure that we're only beginning to understand. And I kind of describe it like the weather system. You know, weather's extremely complicated. Meteorological science can now predict when it's going to rain tomorrow. You know, what if we could predict when someone was going to have a severe pain flare or pain crisis tomorrow? It's actually a lot of the same tools and modeling kind of techniques with machine learning that are derived from physics, meteorology, even astronomy that we're applying to brain science.
Interviewer
We're going to talk a lot more about the stimulators and measuring that. But basically, it sounds like what you're saying. If you have these probes that are in the brain, they can sort of listen in to what's happening, maybe figure out if a pain crisis or a pain event is coming before the person might even recognize it themselves.
Dr. Prasad Srivalkar
Exactly. And we know that there's only a limited part of what our brain does that actually reaches our awareness, right, or our consciousness. And so the hope is, if we can identify or pinpoint these signals before they actually become a problem or bother somebody, that we could short circuit them and try to treat pain that way. And so of all the tools in pain medicine that are available, we have medications, we have physical therapy, acupuncture and other conservative measures are super important. That's where you start. We have injections and nerve blocks that can help for a limited amount of time. Then there's this whole relatively new area of neuromodulation. It involves electrical stimulation of the spinal cord of the brain, of the peripheral nervous system to try to actually reprogram what the nerves are doing.
Interviewer
You do some pretty, pretty cool stuff, I gotta say. It's gotta be very gratifying to work in this area. Such a huge need in cutting edge science. Let me go somewhere decidedly low tech though for a second, just in terms of you being a clinician. Someone comes in with pain and whatever it might be, you want to treat them. Like making simple decisions like using an anti inflammatory like ibuprofen versus Tyle. How do you think about these things?
Dr. Prasad Srivalkar
You know, when we're trying to figure out what medication to recommend to a patient, first I think about, okay, what category or what type of pain are they experiencing? Generally we divide pain into at least three different categories. One of them is myofascial or muscular pain, which means it could be due to knots in the muscle or spastic muscles as a result of posture or even arthritis. Which brings me. Second type of pain is inflammation, arthritis related pain, which is by and large most common type of pain in the world. And then we have this third category we call neuropathic pain, nerve pain. It's electric, it's tingly. So first to try to understand which one of these categories you know, do I think is primarily playing a role. And then based on that, we'll ask the patient, you know, potentially go through some medication options, you know, as well as kind of relying on a wealth of evidence from the literature really. And the state of the art right now for picking a medication for an individual patient is trial and error. So I'll, you know, I'll say here are three drugs, you know, I recommend this one because it might have the best side effect profile for your nerve pain. And then they'll try it and if they have bad symptoms and you know, tell them to stop and then we move on to the next one. But one of the key lessons I learned is, you know, we'll often use medications and doctors and patients will give up on a drug because it doesn't work early on. But really starting low, going slow and being patient, increasing that drug very, very slowly is so critical. And so I really try to, I guess, communicate that patience, but also instill a sense of hope because it is trying to be your own guinea pig. And that's essentially what we're doing right now.
Interviewer
In pain medicine, there's all sorts of injuries that people probably would never come see you for. I mean, they just take care of it at home, sprained ankle, whatever it might be. In those situations, it seems like the mantra has been to tamp down the inflammation as much as possible in the beginning. Taking anti inflammatory medications, ibuprofen, things like that. Do you think that's a good strategy or do we overdo that?
Dr. Prasad Srivalkar
You know, inflammation is not always a bad thing. Sometimes there's good inflammation. When we have an infection, we want to be able to fight that infection. That inflammation can actually help. There's some evidence or some reason to believe that overdoing anti inflammatories or overdoing the, you know, suppressing the body's own natural healing process might actually make people more prone to chronic pain in the future. And so I think that's a really important question to ask and investigate. But fundamentally, you know, it's still a mystery. I think certainly the way that we treat something early on almost definitely influences the kind of trajectory in neurology. We have this concept of medication overuse headache. People often have headaches, migraines are very common. They'll take a medication, then they get used to taking that medication, and all of a sudden you can develop a secondary headache from overusing a medication. And that can be really hard to tease apart.
Interviewer
It's interesting that you've probably seen some of these studies, but this idea of predicting who's most likely to have chronic pain, there was some correlation with the lowest levels of inflammation at the time of injury. So people who had very low levels of inflammation, even though they may have had less acute pain, were more likely to have chronic pain, which I thought was really interesting.
Dr. Prasad Srivalkar
That is fascinating, right. What that tells me is that there's something genetic or hardwired that predisposes some folks to developing chronic pain. And understanding what that is is going to be one of the big challenges in the next 10 years. It almost certainly involves kind of genetics. Our immune system, our microbiome in our gut, involves our upbringing, our history of trauma. You know, all of this comes to bear because pain, you know, it's not just an unpleasant sensation, right? It actually impacts emotion. It impacts the way that we think, it impacts our relationships with family members. There's all these elements that bleed into almost every aspect of being human, which makes it so challenging to treat.
Dr. Sanjay Gupta
After the break, Dr. Srivalkar breaks down the basics and the potential of this cutting edge research.
Sleep Number Ad
This podcast is supported by Sleep Number we all sleep, but for each of us, our sleep is unique. Sleep Number Smart beds are made to adapt to your changing needs from day to day. Using the science of your sleep, they effortlessly adjust to optimize your comfort. So whether you need softer or firmer, cooler or warmer, you can enjoy your best sleep because it's just right for you. Plus, with our Klymit series, smart beds that cool up to 20 times faster than a leading competitor, and optional dual temp layers, you'll stay perfectly cool even when summer doesn't. Whether you're looking to change your bed's firmness whenever you like, or treat your partner to custom settings on their side of the bed, Sleep Number Smart Bed tracks the evolution and improvement of your sleep, giving you personalized insights designed to make each night's rest even better. Why choose a Sleep Number Smart bed so you can sleep just the way you like. The only bed that lets you make each side firmer or softer whenever you like your Sleep number setting and now save up to $800 on select sleep number smart beds limited time exclusively at a Sleep Number store near you. C Store or Sleep for details this.
Indeed Ad
Episode is brought to you by Indeed. When your computer breaks, you don't wait for it to magically start working again. You fix the problem. So why wait to hire the people your company desperately needs? Use Indeed Sponsored Jobs to hire top talent fast and even better, you only pay for results. There's no need to wait. Speed up your hiring with a $75 sponsored job credit@ Indeed.com podcast. Terms and conditions apply.
Interviewer
So tell me how you got interested in this idea of looking at implants in the brain to try and measure pain. Where did this come from?
Dr. Prasad Srivalkar
So, believe it or not, deep brain stimulation or electrical stimulation of human brains was first studied for chronic pain in 1960. How it came about was there are a lot of people out there with either nerve pain or arthritis related pain or pain, frankly that comes from the brain after a stroke or even from Parkinson's disease. There are people out there that have been failed by all available therapies. You know They've tried over 25 different medications. They have had multiple injections and nerve blocks. They've even had spinal cord stimulators or peripheral stimulators, and nothing can alleviate their suffering. And so really how it came about was understanding or appreciating that the brain must be generating or perpetuating these pain signals in this person. After you appreciate that, the question then becomes, how can we identify what these signals are and really try to suppress them or short circuit them?
Interviewer
If you were to look at some of the data from these deep brain stimulators, could you tell if someone was like, if you knew nothing else about the patient and you're just looking at the brain, could you tell that this is a brain in pain?
Dr. Prasad Srivalkar
Right now, I would say we have computational models that can tell if a specific person was in a high pain state or a low pain state, and we're talking about chronic pain. If someone's suffering from low back pain or even fibromyalgia, what needs to be done is to develop a model that generalizes to hundreds and thousands of people. So we can't do that on a large scale yet, but hopefully we can develop new tools that will generalize to folks without having to insert probes in their brain. Right. To do it in a non invasive way. Sure.
Interviewer
2023, you write a paper, what was the conclusion? What were you trying to convey?
Dr. Prasad Srivalkar
In 2023, we published this report that was the first in human description of an objective brain biomarker that tracked how severe chronic pain was in four individuals. You know, we have the clinical understanding and intuition. Chronic pain is not just a more enduring version of acute pain. You know, when you stub your tov, it's not like if that lasts for four months, it feels like what it is to have chronic foot pain. But it's never convincingly been scientifically shown or studied before. So we performed experiments to understand, okay, how is chronic pain represented in the brain? How is acute pain represented in the brain, and are those two overlapping or how are those two similar? And we found that there's actually quite distinct brain signatures for acute pain and chronic pain when we can predict the severity. So it provided kind of a proof of concept for everyday intuition.
Interviewer
What's the significance of that for you or for someone who's trying to treat it?
Dr. Prasad Srivalkar
You know, it tells me that when someone has developed chronic pain, treating it with a single drug or an injection or some monotherapy probably isn't going to work. So when pain becomes chronic, it starts to take on these Other dimensions that include mood and motivation and involve attention and memory. And so when pain is chronic, we have to address the cognitive aspect of it. We have to address people's thinking patterns, make sure that they're eating well, exercising as much as possible. But that's critical component for chronic pain of recovery. We have to make sure that they're not depressed or if you have depression, that it's treated, because that will prevent you from recovering from chronic pain. And so it really requires kind of a multimodal approach.
Interviewer
You know, it's really interesting. One of your colleagues in pain research said something to me that chronic pain never occurs in isolation. It always comes with pain, baggage attached, depression, anxiety. Is that your experience as well, then?
Dr. Prasad Srivalkar
Absolutely. And we know that having baggage may predispose you to chronic pain. But chronic pain, you know, it's like the unwelcome relative brings their own baggage. We know from a lot of literature, having a traumatic experience in your childhood, whether it's sexual abuse or whether it's some kind of physical trauma, really increase the chance of having chronic pain later in life. And so it's possible. We try to make sense out of it, but it's possible that the pain is arising to alert somebody of, you know, hey, this trauma is still there. You know, it's unaddressed, it's untreated. It may be as simple as that. Pain is a signal that our brain is screaming out to us, trying to.
Interviewer
Ask for help, I guess. Prasad what is interesting to me is the conversation we're having, I feel like is still an unusual conversation in medicine. The idea that, hey, look, psychological trauma from your childhood could be driving physical symptoms in your adulthood. A lot of people still get very squishy about this. They think it's too vague, too hard to describe. Patients think it's all in their head. Do you think we're getting better about that, or are you a bit unusual in terms of how you think about it?
Dr. Prasad Srivalkar
I would say I am unusual in that I'm a neurologist who's interested in pain. Western medicine or our medical system operates with all these kind of independent silos where folks really are experts in what they do. But it's rare often to have a multidisciplinary approach where psychiatrists come to together with neurologists, come together with anesthesiologists. Right. Pain is most often in the hospital, in the department of anesthesiology. And it's been kind of historical, even though the first pain center in this country was, I believe, started by a Neurologist. And so I think I'm unusual in the sense that I'm interested in understanding how all of these disciplines kind of play in together. But I will tell you, there's a huge effort by a lot of really hardworking psychiatrists to develop a new biological psychiatry of the brain to understand the circuit underpinning. How did different electrical activity in the brain give rise to different psychiatric symptoms? I think one, hopefully that'll help us to understand it better so we can treat diseases better. But two, really to destigmatize these diseases, to say, hey, this is the biomarker. This is a pattern that we're observing and I can show it to you here on the screen. And I think that'll go a long way.
Interviewer
It seems like a really worthy goal, but an audacious one at that. The idea that ultimately, by looking inside your brain, non invasively or invasively, the idea that by looking inside your brain, you might be able to tell the quality and the amount or quantity of someone's pain. That's an extraordinary sort of idea.
Dr. Prasad Srivalkar
Yeah, it sounds a bit like mind reading. Right? Which is a scary thought. And you know, I should say there's a downside to this idea, right. If we can discover brain activity patterns that tell us about someone's thoughts or what they're feeling, we have to, I think, have some humility and acknowledge this is never going to be the end all be all. At the end of the day, the ground truth is what the person tells me. And these biomarkers should never be used to undermine or distrust patients. On the contrary, I think they can actually be used as a validation when there's no other evidence. The MRIs are not, you know, and your blood tests are normal. There's no other evidence that they're in pain. Finding a biomarker, I think can go a long way to actually bringing closure to someone's experience and saying, hey, you know, there's evidence. Here it is. There's this really silly moment in the movie Contact, you know, where. Who is it? I think Jodie Foster. You know, it's like out in outer space or she's traveling between dimensions and she looks out into, into space. She's a very accomplished scientist in the movie astronaut and she says they should have sent a poet. The point is, there's attributes to being human that you can't put on paper. And so at the end of the day, even for understanding pain, understanding what an individual is going through, taking them at their word is the most important thing.
Dr. Sanjay Gupta
You know, I gotta tell you, I've been a journalist for a long time and this was a conversation that really impacted me partly because of the remarkable science. I mean, think about it. A human brain has about 86 billion neurons, but somehow researchers like Shivalkar have been able to make sense of them in some way. Enough so that we may be able to soon anticipate and even interrupt someone's chronic pain. But I think what really stayed with me was Dr. Srivalkar's entire approach, because I think he's got this right. The point of developing these amazing technologies isn't to cast doubt on the patient. Patients like Ed, the 51 year old musician who had lifelong pain that we met at the top of the episode. A patient's lived experience should always be the North Star, no matter what the deep brain stimulators are telling you. But the technology can help. It can help point physicians in the right direction and hopefully provide better care. It is the future that people have been hoping for when it comes to chronic pain for a long time. And if you've enjoyed this conversation, consider checking out my new book. I write all about this because I found it so fascinating. The book is called it doesn't have to Hurt your Smart Guide to a Pain Free Life.
Interviewer
Thanks for listening.
Sleep Number Ad
We all sleep, but no two sleepers are the same. That's why Sleep Number Smart beds are designed to adapt to you. With Sleep Number it's easy and your side of the bed can be totally different from your partner's. Why choose a Sleep Number Smart bed so you can sleep just the way you like. The only bed that lets you make each side firmer or softer whenever you like your Sleep Number setting and now save up to $800 on select sleep Number Smart Beds Limited time exclusively at a Sleep Number store near you. See store or sleepnumber.com for details.
Michael Bungay Stanier
Your change strategy has gaps you can't see. I'm Michael Bunge Stanier, host of Change Signal, the podcast that helps you find the blind spots that sink transformations. If you want to be a masterful Change leader, Change Signal will be your favorite podcast. Find it wherever you get your podcasts and follow so you never miss an episode.
Host: Dr. Sanjay Gupta
Episode Release Date: August 8, 2025
In this episode of Chasing Life, Dr. Sanjay Gupta delves into the complexities of pain diagnosis and management. Traditional methods, often relying on subjective scales like the 1 to 10 pain rating or emoticon-based tools, are inadequate for capturing the true nature of an individual's pain experience. Dr. Gupta introduces listeners to groundbreaking research aimed at revolutionizing how we understand and treat chronic pain.
The episode begins with the story of Ed Mowry, a 51-year-old musician who has endured complex regional pain syndrome since age 15. [00:00]
Dr. Sanjay Gupta: "When Ed Mowry stepped into Dr. Prasad Srivalkar's office in 2021, he had undoubtedly answered that question hundreds of times... He described it as a sharp, stabbing burning over his entire body and he had no clear explanation why."
Ed's persistent pain had led to 25 surgeries and an inability to maintain employment, overshadowing his passion for music. Seeking relief, he turned to Dr. Prasad Srivalkar, a specialist in pain medicine at the University of California, San Francisco, renowned for his research in deep brain stimulation (DBS) therapies.
Dr. Srivalkar's pioneering work focuses on using DBS to target specific areas of the brain responsible for pain perception. This method involves implanting electrodes to stimulate brain regions, potentially alleviating chronic pain where traditional treatments have failed. However, pinpointing the exact location within the brain remains a formidable challenge.
Dr. Prasad Srivalkar: "The whole team were in there for eight to 10 hours every day for 10 days, and we didn't find anything. And I think it was day five or six that we had a kind of eureka moment when all of a sudden Ed says, my pain, you know, just washed off of me." [02:07]
Ed's sudden relief after prolonged exploration underscored the potential of DBS, affirming that Dr. Srivalkar's efforts were far from futile.
A significant portion of the discussion centers on the difficulty of diagnosing pain objectively. Unlike measurable vital signs such as temperature or heart rate, pain lacks a tangible metric, historically referred to as the "fifth vital sign."
Dr. Prasad Srivalkar: "One of the holy grails of pain medicine has been coming up with a biomarker for measuring how intense or how severe somebody's pain is." [07:46]
Dr. Srivalkar elaborates on his lab's efforts to identify brain signals that correlate with pain intensity, aiming to develop a biomarker that could objectively quantify pain levels. This advancement could transform pain management, especially for individuals unable to communicate their pain effectively, such as those with dementia.
The conversation shifts to current pain treatment strategies, highlighting the limitations of existing modalities. Dr. Srivalkar categorizes pain into three main types:
Dr. Prasad Srivalkar: "When pain becomes chronic, it starts to take on these other dimensions that include mood and motivation and involve attention and memory." [21:41]
Chronic pain, unlike acute pain, involves complex interactions between physical sensations and psychological factors, necessitating a multimodal treatment approach. Dr. Srivalkar emphasizes the importance of addressing cognitive aspects, such as depression and anxiety, which often accompany chronic pain.
Dr. Srivalkar discusses the historical dominance of opioids in pain management and the consequent lack of investment in alternative therapies.
Dr. Prasad Srivalkar: "There’s been a bit of a monopoly from the opiate manufacturers... the money wasn’t flowing elsewhere." [05:07]
The opioid epidemic has underscored the urgent need for non-addictive pain treatments, driving research into innovative solutions like DBS and other neuromodulation techniques.
A crucial theme is the intricate link between chronic pain and mental health. Dr. Srivalkar points out that chronic pain often coexists with depression, anxiety, and a history of trauma, complicating treatment.
Dr. Prasad Srivalkar: "Having a traumatic experience in your childhood... really increases the chance of having chronic pain later in life." [16:49]
Understanding these connections is vital for developing comprehensive treatment plans that address both physical and psychological components of pain.
Looking ahead, Dr. Srivalkar is optimistic about the development of reliable pain biomarkers. His 2023 study marked a significant milestone by identifying distinct brain signatures for acute versus chronic pain, laying the groundwork for future research.
Dr. Prasad Srivalkar: "We have the clinical understanding and intuition. Chronic pain is not just a more enduring version of acute pain... we found that there's actually quite distinct brain signatures for acute pain and chronic pain." [20:33]
However, he also cautions against over-reliance on these technologies. While biomarkers could enhance pain assessment, they should complement rather than replace patient-reported experiences.
Dr. Prasad Srivalkar: "The ground truth is what the person tells me. These biomarkers should never be used to undermine or distrust patients." [25:52]
Dr. Sanjay Gupta wraps up the episode by emphasizing the delicate balance between technological advancements and the human aspect of pain treatment. He highlights Dr. Srivalkar's commitment to using technology to support, not supplant, the patient-physician relationship.
Dr. Sanjay Gupta: "...the technology can help point physicians in the right direction and hopefully provide better care. It is the future that people have been hoping for when it comes to chronic pain for a long time." [27:27]
Dr. Gupta also mentions his upcoming book, reinforcing the episode's message that chronic pain management is an evolving field poised for significant breakthroughs.
This episode of Chasing Life provides an insightful exploration into the future of pain management, blending cutting-edge science with compassionate patient care. For those grappling with chronic pain or interested in the latest medical advancements, Dr. Sanjay Gupta and Dr. Prasad Srivalkar's dialogue offers hope and a vision for a more effective and empathetic approach to pain.